Pulse Biosciences, Inc. Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
Pulse Biosciences, Inc. (PLSE) had Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax of $1.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2020-03-16
- 2018-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $1.00K.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $51.00K.
- 2016-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $7.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax |
|---|---|
| 2018-12-31 | $1.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $51.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $7.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |